Search: WFRF:(Rudolph Tanja) > The Early neo2 Regi...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 05341naa a2200589 4500 | |
001 | oai:lup.lub.lu.se:63977c1e-e0ff-4230-9be4-9abcdacf8eee | |
003 | SwePub | |
008 | 230814s2023 | |||||||||||000 ||eng| | |
009 | oai:prod.swepub.kib.ki.se:153432695 | |
024 | 7 | a https://lup.lub.lu.se/record/63977c1e-e0ff-4230-9be4-9abcdacf8eee2 URI |
024 | 7 | a https://doi.org/10.1161/JAHA.122.0294642 DOI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1534326952 URI |
040 | a (SwePub)lud (SwePub)ki | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a art2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a Rück, Andreasu Karolinska Institutet4 aut |
245 | 1 0 | a The Early neo2 Registry : Transcatheter Aortic Valve Implantation With ACURATE neo2 in a European Population |
264 | 1 | c 2023 |
300 | a 8 s. | |
520 | a BACKGROUND: ACURATE neo2 is a transcatheter aortic valve implantation system consisting of a self-expanding bioprosthetic valve with supra-annular leaflet position and featuring innovations to facilitate placement accuracy and reduce paravalvular regurgitation. METHODS AND RESULTS: The goal of the Early neo2 (Early neo2 Registry of the ACURATE neo2 TAVI Prosthesis) was to gather real-life data on safety and efficacy in a European transcatheter aortic valve implantation population treated with ACURATE neo2. Data were collected from 554 consecutive patients treated with ACURATE neo2 at 12 European sites (mean age, 82 years; 66% women; mean European System for Cardiac Operative Risk Evaluation II, 4.5%±3.8%) between September 2020 and March 2021. The composite primary end point was the occurrence of any of the following: postoperative (in-hospital) paravalvular regurgitation grade ≥2, in-hospital acute kidney injury stage 3, postoperative pacemaker implantation, 30-day death, and 30-day stroke. The primary end point occurred in 12.6% of patients. The 30-day rates for all-cause death and all stroke were 1.3% and 2.7%, respectively, and 1.5% of patients exhibited stage 3 acute kidney injury. A total of 34 patients (6.2%) received a postoperative permanent pacemaker. Per core laboratory–adjudicated echocardiographic analysis, mean postoperative aortic valve gradient was 7.6±3.3 mm Hg, and 2.8% of patients exhibited paravalvular regurgitation grade ≥2. CONCLUSIONS: In this report of postmarket use of the ACURATE neo2 valve in a real-world transcatheter aortic valve implantation population, patients exhibited favorable postoperative hemodynamics and clinical outcomes and a low rate of postoperative pacemaker implantation. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng |
653 | a aortic regurgitation | |
653 | a aortic stenosis | |
653 | a TAVI | |
700 | 1 | a Kim, Won Keunu Max Planck Institute for Heart and Lung Research4 aut |
700 | 1 | a Abdel-Wahab, Mohamedu Leipzig University4 aut |
700 | 1 | a Thiele, Holgeru Leipzig University4 aut |
700 | 1 | a Rudolph, Tanja K.u Ruhr-University Bochum4 aut |
700 | 1 | a Wolf, Alexanderu Elisabeth Hospital Essen4 aut |
700 | 1 | a Wambach, Jan Martinu Elisabeth Hospital Essen4 aut |
700 | 1 | a Backer, Ole Deu Copenhagen University Hospital4 aut |
700 | 1 | a Sondergaard, Larsu Copenhagen University Hospital4 aut |
700 | 1 | a Hengstenberg, Christianu Medical University of Vienna4 aut |
700 | 1 | a Laine, Mikau Helsinki University Central Hospital4 aut |
700 | 1 | a Miyashita, Hirokazuu Helsinki University Central Hospital4 aut |
700 | 1 | a Bjursten, Henriku Lund University,Lunds universitet,Thoraxkirurgi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Skonsammare hjärtkirurgi,Forskargrupper vid Lunds universitet,Thoracic Surgery,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Less invasive cardiac surgery,Lund University Research Groups,Skåne University Hospital4 aut0 (Swepub:lu)thor-hjo |
700 | 1 | a Götberg, Matthiasu Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Skåne University Hospital4 aut0 (Swepub:lu)kard-mgo |
700 | 1 | a Pellegrini, Costanzau Technical University of Munich4 aut |
700 | 1 | a Toggweiler, Stefanu Cantonal Hospital Lucerne4 aut |
700 | 1 | a Wykrzykowska, Joanna J.u University Medical Center Groningen4 aut |
700 | 1 | a Soliman, Osamau Galway University Hospital,National University of Ireland Galway4 aut |
700 | 1 | a Saleh, Nawzadu Karolinska University Hospital4 aut |
700 | 1 | a Meduri, Christopher U.u Karolinska University Hospital4 aut |
710 | 2 | a Karolinska Institutetb Max Planck Institute for Heart and Lung Research4 org |
773 | 0 | t Journal of the American Heart Associationg 12:15q 12:15x 2047-9980 |
856 | 4 | u http://dx.doi.org/10.1161/JAHA.122.029464x freey FULLTEXT |
856 | 4 8 | u https://lup.lub.lu.se/record/63977c1e-e0ff-4230-9be4-9abcdacf8eee |
856 | 4 8 | u https://doi.org/10.1161/JAHA.122.029464 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:153432695 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.